After 24 h, cell lysates were assessed by immunoblot analysis, demonstrating that the R+D ‘pre-treatment’ efficiently inhibited both the mTOR signaling pathway and Src kinase activation in monolayers as well as in spheroid cultures for both NB cell lines (Figure 6). This evidence concerns the gene MTOR and neuroblastoma.